-4th largest player in the Indian pharma market. (AWACS March 2016)
-16 of the group’s brands feature amongst the top 300 pharma brands in India. (AWACS March 2016)
World class manufacturing facilities comprising state-of-the-art manufacturing plants for APIs and formulations, including novel dosage forms. Of these, 8 are USFDA inspected.
-Robust regulatory pipeline – more than 100 approvals and has so far filed over 270 ANDAs . The group has filed 122 DMFs. (as 31st March 2016)
-The first Indian pharma company to launch an NCE in the market with Lipaglyn, the world’s first drug to treat diabetic dyslipidemia.
-Launched the world’s first biosimilar of Adalimumab ‘Exemptia’ to treat inflammatory arthritis.
Robust innovation pipeline with over 1200 researchers working across 8 R&D centres of excellence focused on small molecules, biologics, vaccines, formulation development and API process research.
-Partner of Choice for research-driven pharma majors like Abbott, Hospira, Bayer, Takeda, IDRI, Pieris AG, Prolong Pharmaceuticals and the World Health Organisation to name a few.
If dose missed—>
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
Please consult your doctor if you have missed too many doses in the recent past.
If had overdose—>
If you suspect that you or anyone else may have taken an overdose, then please contact your Doctor asap as they may cause poisoning or serious side effects to the body.
Still if your disease symptoms look similar to another person’s disease symptoms, never share your medicine to that person.
Storage—> Store in normal & dry place.